University College London (UCL)

University / College


Location: London, United Kingdom (GB) GB

ISNI: 0000000121901201

ROR: https://ror.org/02jx3x895

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium (2017) Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, et al. Journal article Interrelation of depression, sexual dysfunction and disease severity in patients with multiple sclerosis (2017) Hoesl K, Roy S, Wang R, Intravooth T, Deutsch M, Winder K, Lee DH, et al. Conference contribution Cardiovagal responses to autonomic challenges are reduced after six months of Fingolimod-therapy in patients with multiple sclerosis (2017) de Rojas Leal C, Wang R, Roy S, Liu M, Canavese F, Hoesl K, Winder K, et al. Conference contribution Autonomic challenges suggest that Fingolimod induced cardiac autonomic changes might be reversible (2017) Wang R, Roy S, de Rojas Leal C, Liu M, Hoesl K, Lee DH, Linker R, Hilz MJ Conference contribution Genetic variation of PNPLA3 and TM6SF2 associate with hepatocellular carcinoma in patients with alcohol-related cirrhosis (2017) Stickel F, Buch S, Janet F, Rosendahl J, Morgan MY, Nischalke HD, Lammert F, et al. Conference contribution PREDICTION OF PROGRESSIVE SKIN THICKENING IN EARLY DIFFUSE SYSTEMIC SCLEROSIS USING THREE-MONTHLY SKIN SCORES FROM THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY (ESOS) (2017) Herrick A, Peytrignet S, Pan X, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2017) Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, et al. Conference contribution Doxycycline versus Prednisolone for the initial Treatment of bullous Pemphigoids: a pragmatic prospective randomized Study (2017) Schmidt E, Benoit S, Ehrchen J, Glaeser R, Guenther C, Steinbrink K, Sticherling M, et al. Conference contribution The Histone Demethylase Jumonji Domain-Containing Protein 3 (JMJD3) As Central Mediator of Fibroblast Activation (2017) Bergmann C, Brandt A, Dees C, Zhang Y, Chen CW, Mallano T, Wohlfahrt T, et al. Conference contribution European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes (2017) Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, et al. Journal article